GO
Loading...

Endo Health Solutions Inc

More

  • *Endo offers $33.25/ share for Auxilium. Oct 9- Endo International Plc brought a successful end to its month-long pursuit of Auxilium Pharmaceuticals Inc, with the smaller rival choosing a sweetened offer over its agreement to buy Canadian eye-drug maker QLT Inc.. "Endo recognizes the value inherent to Xiaflex, given the drug's potential in multiple additional...

  • NEW YORK, Oct 9- U.S. stock index futures pointed to a lower Wall Street open on Thursday, with earlier gains erased as concerns about global growth spurred investors to take profit following a massive advance in the previous session. The third-quarter earnings season got off to a strong start, with both Alcoa Inc and PepsiCo Inc rallying in premarket trading...

  • Oct 9- Auxilium Pharmaceuticals Inc agreed to be bought by Endo International Plc for $1.67 billion and terminated its deal to buy Canadian eye-drug maker QLT Inc.. Endo moved its tax domicile to Ireland from Pennsylvania last year when it bought Canadian drugmaker Paladin Labs Inc.. Citi is Endo's financial adviser and Sullivan& Cromwell LLP is its legal...

  • NEW YORK, Oct 9- Alcoa Inc and PepsiCo Inc were among Thursday's biggest premarket movers, with both rallying on strong results. Aluminum maker Alcoa jumped 1.6 percent to $16.32, a day after its third-quarter earnings beat expectations on higher aluminum prices and lower costs. The results contributed to a positive tone on Wall Street as Alcoa was one of the...

  • Oct 9- Endo International Plc said it would buy Auxilium Pharmaceuticals Inc in a deal valued at $2.6 billion, including the repayment and assumption of debt. Endo's offer of $33.25 per share represents a premium of about 12 percent to Auxilium's Wednesday close and is higher than Endo's previous offer of $28.10. As part of the deal, Auxilium terminated its...

  • Oct 3- A jury award of $73.4 million to a woman who said she was injured by a Boston Scientific Corp transvaginal mesh device has been cut to $34.6 million, thanks to a Texas law that caps how much companies must pay in punitive damages. Last month, jurors in Dallas found Boston Scientific liable for selling a defective Obtryx sling that was implanted in plaintiff...

  • After-Hours Buzz: CSTR, PRGS & More Thursday, 3 Jan 2013 | 4:39 PM ET
    market-insider-stocks-to-watch-AB-200.jpg

    Check out which companies are making headlines after the bell Thursday:

  • After-Hours Buzz: Juniper, Boston Beer & More Wednesday, 12 Dec 2012 | 5:42 PM ET
    market-insider-stocks-to-watch-AB-200.jpg

    Check out which companies are making headlines after the bell Wednesday.

  • Why Samsung Stock Surge Won’t Fizzle Out Like Apple’s

    Shares of Samsung Electronics, which have surged almost 35 percent since the start of the year, closed at an all-time high on Thursday boosted by expectations that its smartphone business will continue to drive strong profit growth.

  • Here Are Small Cap Values: Gabelli Wednesday, 21 Nov 2012 | 1:39 PM ET
    Here Are Small Cap Values: Gabelli

    With bigger companies looking to grow, many may look to acquire smaller firms. That’s one of the reasons Mario Gabelli, chairman of Gamco Investors, sees opportunity in small-cap equities.

  • Oct 11- Endo Health Solutions Inc:. *FDA- became aware of cases of a serious blood disorder in individuals abusing. *FDA says the disorder related to Endo's Opana ER resulted in kidney failure.

  • Opana, a powerful opioid painkiller containing oxymorphone, is produced by Endo Pharmaceuticals. The blood disorder, thrombotic thrombocytopenic purpura, resulted in kidney failure requiring dialysis in some cases and at least one death, the Food and Drug Administration said.

  • Abuse of painkiller Opana can cause blood disorder-US FDA Thursday, 11 Oct 2012 | 12:12 AM ET

    Opana is produced by Endo Pharmaceuticals. The blood disorder, thrombotic thrombocytopenic purpura, resulted in kidney failure requiring dialysis in some cases, and at least one death, the Food and Drug Administration said. The FDA said problems appear to occur with Opana ER only when it is abused and injected intravenously.

  • Oct 9- Endo Health Solutions Inc:. Reuters Station users, click. 1568. Reuters Station users, click. 4899.

  • Oct 5- Endo Health Solutions Inc:. *Oppenheimer cuts Endo Health Solutions Inc price target to $42 from. Reuters Station users, click. 1568.

  • Oct 5- Endo Health Solutions Inc:. *UBS cuts Endo Pharmaceuticals price target to $45 from $50; rating. Reuters Station users, click. 1568.

  • Oct 5- Endo Health Solutions Inc:. *ThinkEquity cuts Endo Health Solutions price target to $40 from $45;. Reuters Station users, click. 1568.

  • Oct 5- Endo Health Solutions Inc:. *RBC cuts Endo Health Solutions Inc to sector perform from outperform. Reuters Station users, click. 1568.

  • The S&P 500 rose for a fourth session after a report suggested improvement in the labor market ahead of Friday's closely watched monthly payrolls report. The Nasdaq Composite Index gained 6.10 points, or 0.19 percent, to 3,141.40. **COLLABRX INC, $6.80, up 79.4 pct.

  • Oct 3- Endo Health Solutions Inc:. *Credit Suisse cuts Endo Health Solutions target price to $36 from. Reuters Station users, click. 1568.